N. Coussens, R. Parchment, J. Moscow, L. Doyle, R. Delosh, J. Laudeman, R. Reinhart, C. Ogle, T. Silvers, T. Dexheimer, Joel Morris, B. Teicher, J. Doroshow
{"title":"摘要/ Abstract摘要:DNA损伤剂替莫唑胺和trabectedin与DNA修复抑制剂联合筛选,采用复杂球体模型与患者来源和已建立的肿瘤细胞系","authors":"N. Coussens, R. Parchment, J. Moscow, L. Doyle, R. Delosh, J. Laudeman, R. Reinhart, C. Ogle, T. Silvers, T. Dexheimer, Joel Morris, B. Teicher, J. Doroshow","doi":"10.1158/1538-7445.AM2021-1072","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":12258,"journal":{"name":"Experimental and Molecular Therapeutics","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Abstract 1072: Combination screening of DNA damaging agents temozolomide and trabectedin with inhibitors of DNA repair using a complex spheroid model with a panel of patient-derived and established tumor cell lines\",\"authors\":\"N. Coussens, R. Parchment, J. Moscow, L. Doyle, R. Delosh, J. Laudeman, R. Reinhart, C. Ogle, T. Silvers, T. Dexheimer, Joel Morris, B. Teicher, J. Doroshow\",\"doi\":\"10.1158/1538-7445.AM2021-1072\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":12258,\"journal\":{\"name\":\"Experimental and Molecular Therapeutics\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Experimental and Molecular Therapeutics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1158/1538-7445.AM2021-1072\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental and Molecular Therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1158/1538-7445.AM2021-1072","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Abstract 1072: Combination screening of DNA damaging agents temozolomide and trabectedin with inhibitors of DNA repair using a complex spheroid model with a panel of patient-derived and established tumor cell lines